NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Balaji Amines' Share Price Surges 20% Amid Strong Q4 Results

In Thursday's trading session, Balaji Amines' share price skyrocketed 20% to hit the upper circuit at ₹1,623.40 apiece on the National Stock Exchange (NSE). The small-cap stock opened at ₹1,496 apiece today, compared to the previous close of ₹1,352 on Wednesday.

The company's Q4 results for the quarter ended March 31, 2026, revealed a net profit of ₹63.2 crore, marking a 57.8% year-on-year (YoY) increase from ₹40.1 crore in the same period last year. Revenue from operations grew 11.9% YoY to ₹394.8 crore, compared with ₹352.7 crore in the corresponding quarter of the previous fiscal.

SegmentQ4 2026 RevenueQ4 2025 RevenueYoY Growth
Amines & Speciality Chemicals₹393.5 crore₹350.9 crore12.1%
Hotel Division₹8.4 crore₹9.3 crore-9.7%

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

EBITDA surged 58% to ₹94.2 crore from ₹59.7 crore a year earlier, while EBITDA margin widened to 23.9% from 16.9%. On the segment front, profit before tax for the Amines & Speciality Chemicals segment rose to ₹83.7 crore from ₹51.4 crore, while the Hotel Division posted a profit before tax of ₹1.6 crore, compared with ₹2 crore in the corresponding period last year.

The board also recommended a final dividend of ₹11 per equity share, representing 550% of the face value of ₹2 per share. The dividend will be paid subject to shareholder approval at the company's 39th Annual General Meeting.

Balaji Amines' share price trend has been positive in the near term, despite weak market sentiment. The small-cap stock has given 6.36% gain in a week and 50% in a month. Furthermore, the small-cap chemical stock has delivered 46% returns on a year-to-date (YTD) basis and 20% in a year. However, the stock has failed to impress long-term investors as it has shed 31.54% in three years and 32.53% in five years.

Investor Takeaway

Investors should consider Balaji Amines for its strong fourth-quarter earnings.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.